DARUNAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR ALAFENAMIDE
darunavir 800 mg + cobicistat 150 mg + emtricitabine 200 mg + tenofovir alafenamide
10 mg tablet, 30
DARUNAVIR + COBICISTAT + EMTRICITABINE + TENOFOVIR ALAFENAMIDE (11955F)
11955F
Manner of administration:Oral
Restriction 10324
Indication: HIV infection
Treatment phase: Initial treatment
Restriction 10317
Indication: HIV infection
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 2 | Max qty units: 60 | # of repeats: 5 | DPMQ: $1,711.90 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Symtuza | |||||
